<DOC>
	<DOCNO>NCT00000701</DOCNO>
	<brief_summary>The study design test drug zidovudine ( AZT ) child , include study drug level various part body fluid , safety drug , effect different part body . The effect drug , way drug enters bloodstream , way use body , way body eliminate drug may different child compare adult . The large group child AIDS le 2 year age . AIDS often first identify infant 6 month old . Studies AZT show might useful treatment AIDS . Thus important study effect drug child .</brief_summary>
	<brief_title>A Phase I Evaluation Azidothymidine ( AZT ) Children With Acquired Immune Deficiency Syndrome ( AIDS ) AIDS Related Complex ( ARC )</brief_title>
	<detailed_description>The effect drug , way drug enters bloodstream , way use body , way body eliminate drug may different child compare adult . The large group child AIDS le 2 year age . AIDS often first identify infant 6 month old . Studies AZT show might useful treatment AIDS . Thus important study effect drug child . Patients hospitalize 8 week receive AZT intravenous ( IV ) route 1 2 dos . Patients discharge hospital take AZT mouth 4 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>AIDS-Related Complex</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Treatment : Allowed : Nutritional support exceed 120 calories/kg/day ( hyperalimentation dietary supplement include vitamin , folate , iron supplement ) . Exclusion Criteria Coexisting Condition : Children follow condition exclude : Asymptomatic Tlymphocyte deficiency . Asymptomatic viremic patient meet definition criterion AIDS relate complex ( ARC ) AIDS . Clinical evidence active infection acute nature active significant clinically apparent opportunistic infection time entry study . Hemoglobinopathy include sickle cell anemia . Congenital infection toxoplasmosis herpes simplex virus infection first month birth cytomegalovirus infection first 6 month birth . Children follow condition exclude : Asymptomatic Tlymphocyte deficiency . Asymptomatic viremic patient meet definition criterion AIDS relate complex ( ARC ) AIDS . Clinical evidence active infection acute nature active significant clinically apparent opportunistic infection time entry study . Hemoglobinopathy include sickle cell anemia . Congenital infection toxoplasmosis herpes simplex virus infection first month birth cytomegalovirus infection first 6 month birth . Prior Medication : Excluded : Suramin . Ribavirin . HPA 23 . Phosphonoformate . Ansamycin . Interleukin 2 . Interferon . Excluded within 30 day study entry : All cytolytic chemotherapeutic agent , immunomodulating agent include steroid immunoglobulin preparation . Antivirals ( acyclovir , ganciclovir ) . Prior Treatment : Excluded within 4 week study entry : Lymphocyte transfusion immune reconstitution . Excluded within 3 month study entry : Bone marrow transplant . Child seropositive HIV antibody HIV viremia present one follow clinical criterion least one laboratory criterion may consider ARC patient purpose study : Clinical criterion : Persistent oral candidiasis despite appropriate therapy . Wasting syndrome characterized failure thrive malnutrition . Recurrent chronic unexplained diarrhea . Lymphadenopathy ( 1 cm ) 2 noncontiguous site . Hepatomegaly without splenomegaly . Encephalopathy loss developmental milestone cortical atrophy present compute tomography ( CT ) examination . Recurrent bacterial infection ( bacteremia , pneumonia , septic arthritis , meningitis ) . Cutaneous anergy define lack delay cutaneous hypersensitivity select antigen . Laboratory criterion : Hypergammaglobulinemia ( IgG IgA ) define immunoglobulin value exceed maximum ageadjusted level . Decreased number total Tlymphocytes ( 2 SD mean ) . Absolute depression Thelper cell less 500/mm3 . Depressed ( equal 2 SD normal mean ) vitro mitogen response least one antigen . One positive HIV culture within 3 month study entry study blood obtain culture pending . Life expectancy great 6 month . Ambulatory free opportunistic infection time entry . Reliably diagnosed disease least moderately indicative underlie cellular immunodeficiency know cause underlie cellular immunodeficiency reduce resistance report associated disease . Disease accept sufficiently indicative underlie cellular immunodeficiency CDC . In absence opportunistic disease , histologically confirm diagnosis chronic lymphoid interstitial pneumonitis consider indicative AIDS unless test ( ) HIV negative .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Drug Evaluation</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Zidovudine</keyword>
</DOC>